Moubarak in Therapeutic Advances in Neurological Disorders Supplemental material, sj-xlsx-3-tan-10.1177_17562864251378845 for The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis by Jamal Ahmad, Ahmed Mohamed Hamdy, Bahaa Elfakharany, Muhammad M
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 17 trials
Making sure you have safe access to semaglutide is very important for the best treatment
The offer is available through multiple platforms so that patients with a prescription for real, FDA-approved Ozempic can access it in the way that suits them best
However, more long-term, controlled studies are needed to establish the safety of the proposed therapy